Nicholas Tish
Registered
Hello guys, this is my very first post!
We are developing a diagnostic device that senses some electrical signals from the patient via surface electrodes.
Our team is discussing risks related to motion artifacts, loss of contact, and all the problems that come when sensing electrical signals through surface electrodes. From an engineering perspective we put in place software algorithms to detect anomalies on the readings and dismiss noisy or useless signals. Each time that the algorithm detects a problem, a warning message is presented on the screen and the readings are discarded.
The problem is that we are not quite sure about what kind of risk mitigation can we claim under this approach. The arguments within the team are for claiming ‘inherent safety’ are:
Arguments in favour of regarding this measure as ‘inherent safety’:
-Preventing noisy/useless from entering the algorithms that calculate the clinical information that the device is intended to provide is inherent safe, since no clinical information is presented on the screen and physicians would not make clinical decisions based on the information presented by the device.
Arguments disfavouring ‘inherent safety’:
-This measure is implemented through a software algorithm and software should not be used to mitigate risks.
-If no information is presented to the user, then the decision-making process can be affected resulting in a new risk.
How would you classify this approach? Would you say this is ‘inherent safety’ or just a ‘protective measure’?
I have reviewed the standards several times and I acknowledge lack of experience. I am also aware of the fact that auditors should request for evidence of training and experience. That’s part of reason for which I joined this community.
Thank you in advance
We are developing a diagnostic device that senses some electrical signals from the patient via surface electrodes.
Our team is discussing risks related to motion artifacts, loss of contact, and all the problems that come when sensing electrical signals through surface electrodes. From an engineering perspective we put in place software algorithms to detect anomalies on the readings and dismiss noisy or useless signals. Each time that the algorithm detects a problem, a warning message is presented on the screen and the readings are discarded.
The problem is that we are not quite sure about what kind of risk mitigation can we claim under this approach. The arguments within the team are for claiming ‘inherent safety’ are:
Arguments in favour of regarding this measure as ‘inherent safety’:
-Preventing noisy/useless from entering the algorithms that calculate the clinical information that the device is intended to provide is inherent safe, since no clinical information is presented on the screen and physicians would not make clinical decisions based on the information presented by the device.
Arguments disfavouring ‘inherent safety’:
-This measure is implemented through a software algorithm and software should not be used to mitigate risks.
-If no information is presented to the user, then the decision-making process can be affected resulting in a new risk.
How would you classify this approach? Would you say this is ‘inherent safety’ or just a ‘protective measure’?
I have reviewed the standards several times and I acknowledge lack of experience. I am also aware of the fact that auditors should request for evidence of training and experience. That’s part of reason for which I joined this community.
Thank you in advance